Cytokine signaling and Epstein-Barr virus-mediated cell transformation (Q34234140)

31 July 2017

1 reference

title

Cytokine signaling and Epstein-Barr virus-mediated cell transformation (English)

1 reference

31 July 2017

0 references

Mosialos G

1

1 reference

31 July 2017

publication date

1 June 2001

1 reference

Cytokine and Growth Factor Reviews

31 July 2017

published in

1 reference

31 July 2017

volume

12

1 reference

31 July 2017

issue

2-3

1 reference

31 July 2017

page(s)

259-270

1 reference

Is EBV persistence in vivo a model for B cell homeostasis?

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

EBV persistence in memory B cells in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Regulation of T cell fate by Notch

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

1 reference

7 January 2021

Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

THE ORIGIN OF HODGKIN AND REED/STERNBERG CELLS IN HODGKIN'S DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin's disease at diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Epstein-Barr virus latent membrane protein: induction of B-cell activation antigens and membrane patch formation does not require vimentin

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

High Concentration of the EBV Latent Membrane Protein 1 in Glycosphingolipid-Rich Complexes from both Epithelial and Lymphoid Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Relationship between IkappaBalpha constitutive expression, TNFalpha synthesis, and apoptosis in EBV-infected lymphoblastoid cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Assembly and regulation of the CD40 receptor complex in human B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

The CD40 antigen and its ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

TNF-mediated activation of the stress-activated protein kinase pathway: TNF receptor-associated factor 2 recruits and activates germinal center kinase related

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

ASK1 is essential for JNK/SAPK activation by TRAF2

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting [...]

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

TGF-beta signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Resistance to TGF-beta1 correlates with a reduction of TGF-beta type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Synergistic regulation of the human interleukin-12 p40 promoter by NFkappaB and Ets transcription factors in Epstein-Barr virus-transformed B cells and macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

Interleukin-12 expression in B cells by transformation with Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900035-6

7 January 2021

10.1016/S1359-6101(00)00035-6

Identifiers

DOI

1 reference

31 July 2017

1 reference